Allen, M. F., Hutchinson, J. L., Keith, M., Mallah, S., Corey, R. A., Trory, J. S., . . . Hers, I. (2024). Difluorinated thromboxane A2 reveals crosstalk between platelet activatory and inhibitory pathways by targeting both the TP and IP receptors. Wiley. https://doi.org/10.1111/bph.16435
Chicago-Zitierstil (17. Ausg.)Allen, Megan F., et al. Difluorinated Thromboxane A2 Reveals Crosstalk Between Platelet Activatory and Inhibitory Pathways by Targeting Both the TP and IP Receptors. Wiley, 2024. https://doi.org/10.1111/bph.16435.
MLA-Zitierstil (9. Ausg.)Allen, Megan F., et al. Difluorinated Thromboxane A2 Reveals Crosstalk Between Platelet Activatory and Inhibitory Pathways by Targeting Both the TP and IP Receptors. Wiley, 2024. https://doi.org/10.1111/bph.16435.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.